An underground economy for unapproved slimming medications is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations.
Experimental Treatment Acquiring Popularity Via Social Media
The experimental drug, which is still in clinical trials, is being promoted by online personalities for its alleged fat-burning properties. Followers are encouraged to contact these profiles directly for supplier links, while also receiving promotional offers.
Active Trade on Social Networks
Separately, a flourishing trade exists on messaging services, where communities with thousands of participants share comparison images, administration instructions and claims of next-day British shipping. Sellers market the drug there before redirecting buyers to WhatsApp for purchases.
Learning About The Experimental Drug
This medication is an investigational injectable created by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.
Medical Professionals Voice Concerns
However, doctors and pharmacists have cautions that the sale of what is still an unapproved drug in the United Kingdom is a cause for concern and could result in users injecting products of uncertain source.
Some experts said the demand for retatrutide could be connected to the rising cost of licensed weight loss products such as Mounjaro.
Legal Status and Implementation
Selling retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved drug that cannot be marketed or distributed for personal consumption under the British medical regulations.
Several influencers attempt to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still violate medicines, advertising, and consumer laws, potentially leading to penalties, legal action or imprisonment.
Platform Response and Content Removal
According to TikTok, the platform has taken down problematic content and prohibited associated keywords and query recommendations. The company stated it was committed to keeping the service secure and investing in enhancing enforcement strategies.
Digital Marketplace Activities
Research also discovered groups with up to 9,000 members selling retatrutide using Telegram's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” immediately brings up groups with numerous of members, populated with photos of weight loss, glowing testimonials and detailed instructions for preparing or administering at home.
After moments of joining one community, a seller shared WhatsApp details, where the majority of purchases take place. The seller provided an instruction manual and guaranteed delivery within 48 hours. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None asked about body mass, medical conditions or past usage.
Product Information and Pricing
Inside these groups, posts display black plastic parcels with postal service labels, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, mixed at residence with sterile water, or pre-filled injectors usually sold at £160 for 20mg. When questioned how much time a injector should be used, sellers give contradictory answers varying between a several days to “depends on your body”.
Platform Moderation and Safety Actions
A representative for Telegram stated it regularly moderated dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“Individuals are injecting materials they cannot confirm. Although the research behind this drug is valid, these online products may not contain what they claim,” stated Jason Murphy, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to current price rises for approved weight-loss drugs such as Mounjaro. “With costs increasing, individuals are using social media. But fake treatments are highly dangerous. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she said.
Her staff has previously seen patients injured by self-injection from unverified sources. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your health,” stated Wyllie. “These materials could be impure or incorrectly dosed.”
Manufacturer Statement
A representative from the pharmaceutical company said the substance was in phase 3 research studies and had not been reviewed or approved by any regulatory agency globally. “Consequently at this point no one can market [it] for human use,” they said, adding that any product “misleadingly claiming itself as a Lilly experimental product not yet approved … may expose users to possibly serious medical dangers”.
